Sakar Healthcare Limited · SAKAR
Every Sakar Healthcare Limited result whose ten-session window has closed, judged against the last read made before it. Open a result for the full account: the read, the sessions after, the reported figures, and every morning's read that led up to it. The company's own page →
25results judged
1read right
1read wrong
0flat / no call
23unread
32%beat the market
-0.6%avg vs market, 10d
5.3%avg move, T+1
How the reads on it fared
| Read | Judged | Right | Wrong | Flat | Hit rate | Avg vs mkt | |
|---|---|---|---|---|---|---|---|
| favourable | 1 | 1 | 0 | 0 | 100% | +9.4% | |
| unfavourable | 1 | 0 | 1 | 0 | 0% | +36.1% | |
| unread | 23 | 0 | 0 | 0 | — | -2.6% |
A company that is often read strong and often proves it is one the model understands; one that is read strong and keeps lagging is where the model is wrong about a name, and this table is where that shows first.
Reading the rows
- T+1
- the share's move on the first session after the result, from the close before it
- T+10
- the move over ten sessions, same base
- vs market
- T+10 less NIFTY 50's move over the same ten sessions — the number every read is judged on
- Run-up
- the share's move in the thirty sessions before the result
- Result
- reported profit growth against the company's own last four quarters: good, in line, bad
Each result
25 judged · newest first · open one| Result | Read | Outcome | T+1 | T+10 | vs market | Run-up | Result | Why | |
|---|---|---|---|---|---|---|---|---|---|
| 24 Jul Q1FY27 | favourable | right | +5.6% | +12.8% | +9.4% | -3% | no figures |
|
› |
| 12 May Q4FY26 | unfavourable | wrong | +5.3% | +38.4% | +36.1% | — | no figures |
|
› |
| 5 Feb Q3FY26 | — | unread | +14.2% | +19.4% | +19.7% | +2% | no figures |
|
› |
| 7 Nov Q2FY26 | — | unread | +7.8% | -3.6% | -5.4% | +3% | no figures |
|
› |
| 25 Jul Q1FY26 | — | unread | -3.5% | -10.4% | -9.4% | +16% | no figures |
|
› |
| 15 May Q4FY25 | — | unread | -2.4% | -0.6% | +0.7% | +48% | no figures |
|
› |
| 8 Feb Q3FY25 | — | unread | -9.2% | -10.2% | -5.9% | -8% | no figures |
|
› |
| 22 Oct Q2FY25 | — | unread | -3.3% | -1.5% | -1.5% | -0% | no figures |
|
› |
| 13 Aug Q1FY25 | — | unread | -2.0% | -2.0% | -4.9% | +2% | no figures |
|
› |
| 21 May Q4FY24 | — | unread | +0.2% | -11.2% | -11.6% | -7% | no figures |
|
› |
| 10 Feb Q3FY24 | — | unread | -9.4% | -10.5% | -12.0% | +7% | no figures |
|
› |
| 7 Nov Q2FY24 | — | unread | +2.2% | +7.7% | +5.7% | +16% | no figures |
|
› |
| 14 Aug Q1FY24 | — | unread | -0.9% | +15.6% | +16.1% | +24% | no figures |
|
› |
| 27 May Q4FY23 | — | unread | -0.5% | +3.2% | +2.9% | +12% | no figures |
|
› |
| 11 Feb Q3FY23 | — | unread | -0.8% | -1.8% | +0.8% | -0% | no figures |
|
› |
| 22 Oct Q2FY23 | — | unread | -5.9% | -10.4% | -13.7% | +20% | no figures |
|
› |
| 21 May Q4FY22 | — | unread | -5.6% | +1.2% | -0.7% | +17% | no figures |
|
› |
| 8 Feb Q3FY22 | — | unread | -5.3% | -20.3% | -19.6% | +3% | no figures |
|
› |
| 29 Oct Q2FY22 | — | unread | +1.1% | -1.8% | -3.6% | -8% | no figures |
|
› |
| 12 Aug Q1FY22 | — | unread | +0.3% | -7.2% | -10.6% | +13% | no figures |
|
› |
| 1 Jun Q4FY21 | — | unread | -3.9% | +1.9% | +0.1% | +30% | no figures |
|
› |
| 5 Feb Q3FY21 | — | unread | -7.1% | -8.3% | -8.9% | +4% | no figures |
|
› |
| 30 Oct Q2FY21 | — | unread | -0.5% | -7.3% | -16.3% | +19% | no figures |
|
› |
| 18 Aug Q1FY21 | — | unread | +13.0% | +6.5% | +4.5% | +5% | no figures |
|
› |
| 25 Jun Q4FY20 | — | unread | +23.4% | +17.8% | +13.2% | -1% | no figures |
|
› |